Skip to menu Skip to content Skip to footer

2024

Conference Publication

Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study

Duplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons.

Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study

2023

Conference Publication

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

2023

Conference Publication

Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey

Bell, S., Duplancic, C., Wainwright, C., Thomson, R., Rogers, G., Clements, A. and Floto, R. (2023). Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey. TSANZSRS 2023 Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Christchurch, New Zealand, 25 - 28 March 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14459

Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey

2022

Conference Publication

Non-tuberculous mycobacteria in Australians with cystic fibrosis: a national survey

Duplancic, C., Wainwright, C., Thomson, R., Rogers, G., Clements, A., Floto, R. and Bell, S. (2022). Non-tuberculous mycobacteria in Australians with cystic fibrosis: a national survey. TSANZSRS 2022 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ), Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, virtual, 31 March-2 April 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14216

Non-tuberculous mycobacteria in Australians with cystic fibrosis: a national survey

2019

Conference Publication

High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia

Duplancic, C., Thomson, R., Wainwright, C. and Bell, S. C. (2019). High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia. 33rd Annual North American Cystic Fibrosis Conference, Nashville, TN United States, 31 October – 2 November 2019. Hoboken, NJ United States: John Wiley & Sons.

High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia

2019

Conference Publication

Non-tuberculous mycobacteria infection in people with cystic fibrosis attending cf treatment clinics in Australia

Duplancic, C., Wainwright, C., Thomson, R. and Bell, S. (2019). Non-tuberculous mycobacteria infection in people with cystic fibrosis attending cf treatment clinics in Australia. TSANZ, Gold Coast, QLD, Australia, 29 March-2 April 2019. Hoboken, NJ, United States: John Wiley & Sons.

Non-tuberculous mycobacteria infection in people with cystic fibrosis attending cf treatment clinics in Australia